Pharegis LLC / ООО "Фареджис"
-
- Business address:
3-1 Begovaya str. ("NordStar Tower", 31st fl.), Moscow, Russia 125284
Legal & postal address:
11A-11 Cherkizovskaya B. str., Moscow, Russia 107392
D-U-N-S: 362071645
-
- +7 495 109 8808
-
- +7 985 908 5818 (WhatsApp)
- https://regdrug.com
Pharma Regulatory News
Feed - News and features
- Lifeline for Wolman disease kids as NICE backs Alexion drug Infants with a rare and fatal...
- Dupixent aces second COPD study, setting up FDA filing With a second positive phase 3 trial...
- Is GSK’s Blenrep heading for a renaissance? A year after GSK pulled its...
- Digital programme improves metabolic health in diabetes A comprehensive digital approach to...
PharmaTimes: News RSS
- MHRA launches online eligibility checker tool via the IRP
- New NHS software set to improve care for millions of patients
- Study suggests cognitive decline could be linked to hippocampus shrinkage
- NHS urges individuals to take up cervical screening invitations
- Alladapt’s allergy treatment receives FDA fast track designation
EMA News
- Consumption of antimicrobials in animals reaches lowest level ever in Europe, , 20/11/2023
- Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 2023, CVMP, 10/11/2023
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023, CHMP, 10/11/2023
- Getting ready for EMA’s website relaunch on 5 December 2023, , 09/11/2023
ClinicalTrials.gov News
- Delayed Cold-Stored Platelets -PLTS-1
- Urinary Retention Following taTME VS laTME Total Mesorectal Excision for Rectal Cancer
- ED90 of Bupivacaine After Lidocaine Test Dose With DPE and EPL
- Human Induced Pluripotent Stem Cells Derived Natural Killer Cell(XS005) Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)